chrX-71911307-C-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001013627.3(NHSL2):​c.220C>A​(p.Arg74Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,126,728 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 8/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000022 ( 0 hom. 4 hem. )

Consequence

NHSL2
NM_001013627.3 missense

Scores

1
2
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.19

Publications

0 publications found
Variant links:
Genes affected
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18552521).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.220C>A p.Arg74Ser missense_variant Exon 1 of 8 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSL2ENST00000633930.2 linkc.220C>A p.Arg74Ser missense_variant Exon 1 of 8 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1
ENSG00000300926ENST00000775127.1 linkn.59-594G>T intron_variant Intron 1 of 2
ENSG00000300926ENST00000775128.1 linkn.235+400G>T intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00000887
AC:
1
AN:
112680
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000133
AC:
1
AN:
74948
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000217
AC:
22
AN:
1014048
Hom.:
0
Cov.:
30
AF XY:
0.0000124
AC XY:
4
AN XY:
321580
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23396
American (AMR)
AF:
0.00
AC:
0
AN:
25893
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17744
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46574
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25101
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3309
European-Non Finnish (NFE)
AF:
0.0000274
AC:
22
AN:
803507
Other (OTH)
AF:
0.00
AC:
0
AN:
42878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000887
AC:
1
AN:
112680
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34866
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31085
American (AMR)
AF:
0.00
AC:
0
AN:
10902
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3485
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6203
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
233
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53143
Other (OTH)
AF:
0.00
AC:
0
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 21, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.220C>A (p.R74S) alteration is located in exon 1 (coding exon 1) of the NHSL2 gene. This alteration results from a C to A substitution at nucleotide position 220, causing the arginine (R) at amino acid position 74 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_noAF
Benign
-0.70
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.014
T
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.49
T
M_CAP
Benign
0.075
D
MetaRNN
Benign
0.19
T
MetaSVM
Benign
-1.0
T
PhyloP100
2.2
PrimateAI
Pathogenic
0.88
D
Sift4G
Benign
0.40
T
Vest4
0.36
MutPred
0.27
Gain of phosphorylation at R74 (P = 0.0069);
GERP RS
2.5
PromoterAI
0.070
Neutral
gMVP
0.27
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs946275942; hg19: chrX-71131157; API